Difference between revisions of "Team:TCU Taiwan/Project/Experimental"
Phoebe chen (Talk | contribs) |
|||
(16 intermediate revisions by one other user not shown) | |||
Line 51: | Line 51: | ||
<td width="3%"></td> | <td width="3%"></td> | ||
<td> | <td> | ||
− | <p align="justify" ><span style="font-family:Calibri;line-height: 150%; | + | <p align="justify" ><span style="font-family:Calibri;line-height: 150%;letter-spacing: 1px;"><font size="5"> |
− | To increase efficiency in isolating our AMPs, we introduced a signal peptide upstream of the N-terminal of antimicrobial peptides to facilitate peptide production. This signal peptide is obtained from chitinase C of <I>S.lividans</I> ( | + | To increase efficiency in isolating our AMPs, we introduced a signal peptide upstream of the N-terminal of antimicrobial peptides to facilitate peptide production. This signal peptide is obtained from chitinase C of <I>S.lividans</I> (MGFRHKAAALAATLALPLAGLVGLASP</br>AQA). After translation process, this signal peptide will lead AMPs to the secretion system of <I>E. coli</I>. When the fusion peptides enter the periplasmic space, peptidase will identify the cleavage site Ala-Gln-Ala and cut at the double Ala at the signal and AMPs linkage site. This separates the signal peptide from the AMPs. To verify the <I>E. coli</I> secretion of AMPs to the LB culture medium, we attached an Ala at the N-terminal of AMPs.<a href="#tcu_sing_references_1">[1,2]</a> |
<br><br> | <br><br> | ||
By modifying the amino acid sequence of Signiferin and Epinecidin-1 to facilitate the secretion process, we can apply structure prediction software to analyze the attached Ala and it’s effect on the peptide folding process, as described in our <a href="https://2015.igem.org/Team:TCU_Taiwan/Modeling/Protein_structure">modeling page</a>. | By modifying the amino acid sequence of Signiferin and Epinecidin-1 to facilitate the secretion process, we can apply structure prediction software to analyze the attached Ala and it’s effect on the peptide folding process, as described in our <a href="https://2015.igem.org/Team:TCU_Taiwan/Modeling/Protein_structure">modeling page</a>. | ||
Line 67: | Line 67: | ||
</div> | </div> | ||
− | <div id="form1" style="background: rgba(100%,100%,100%,0 | + | <div id="form1" style="background: rgba(100%,100%,100%,0); overflow-x:hidden;overflow-y:hidden; "> |
− | < | + | <p align="center"> |
+ | <img src="https://static.igem.org/mediawiki/2015/e/e6/TCU_Taiwan_Signal_Peptide.jpeg"> | ||
+ | <br><br> | ||
+ | <font size="5">Fig.1 Signiferin fusion peptide design model</font> | ||
+ | <br><br><BR><BR> | ||
+ | <img src="https://static.igem.org/mediawiki/2015/3/3c/TCU_Taiwan_Signal_Peptide_2.jpeg"> | ||
+ | <br><br> | ||
+ | <font size="5">Fig.2 Epinecidin-1 fusion peptide design model</font> | ||
+ | </p> | ||
</div> | </div> | ||
<a name="tcu_sing_references_1"></a> | <a name="tcu_sing_references_1"></a> |
Latest revision as of 18:52, 18 September 2015
Signal Peptide |
To increase efficiency in isolating our AMPs, we introduced a signal peptide upstream of the N-terminal of antimicrobial peptides to facilitate peptide production. This signal peptide is obtained from chitinase C of S.lividans (MGFRHKAAALAATLALPLAGLVGLASPAQA). After translation process, this signal peptide will lead AMPs to the secretion system of E. coli. When the fusion peptides enter the periplasmic space, peptidase will identify the cleavage site Ala-Gln-Ala and cut at the double Ala at the signal and AMPs linkage site. This separates the signal peptide from the AMPs. To verify the E. coli secretion of AMPs to the LB culture medium, we attached an Ala at the N-terminal of AMPs.[1,2]
|
Fig.1 Signiferin fusion peptide design model
Fig.2 Epinecidin-1 fusion peptide design model
Contact us tcutaiwan@gmail.com No.701, Sec. 3, Zhongyang Rd. Hualien 97004, Taiwan |